Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Basic data given, acceptable for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1985
Report date:
1985

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
yes
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
tert-butylamine
EC Number:
200-888-1
EC Name:
tert-butylamine
Cas Number:
75-64-9
Molecular formula:
C4H11N
IUPAC Name:
2-methylpropan-2-amine
Details on test material:
- Name of test material (as cited in study report): tert.-butylamine, substance no. 84/396
- Analytical purity: 98%

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Dr. K. Thomae GmbH, Biberach, Germany
- Fasting period before study: 16 hours
- Housing: groups of 5 in stainless steel wire mesh cages type DK-III
- Diet: Kliba laboratory diet, Klingenthalermuehle AG, Kaiseraugst, Switzerland ad libitum
- Water: tap water ad libitum
- Acclimation period: at least 1 week


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 3.61, 4.64, 6.81 (w/v), respectively
- Justification for choice of vehicle: Aqueous formulation corresponds to the physiological medium

MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg

Doses:
316, 464, 681 mg/kg bw
No. of animals per sex per dose:
5 males, 5 females per dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: several times daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight

Results and discussion

Effect levelsopen allclose all
Sex:
male
Dose descriptor:
LD50
Effect level:
> 316 - < 464 mg/kg bw
Sex:
female
Dose descriptor:
LD50
Effect level:
514 mg/kg bw
Sex:
male/female
Dose descriptor:
LD50
Effect level:
ca. 464 mg/kg bw
Mortality:
681 mg/kg dosing group: 5/5 females, 4/5 males (d 1-d 14)
464 mg/kg dosing group: 1/5 females, 5/5 males (d 1-d 14)
316 mg/kg dosing group: no death occurred
Clinical signs:
other: dyspnoea, apathy, staggering, tremors, piloerection, diarrhea, salivation, stretching, imbalance, poor general condition
Gross pathology:
mid and high dosing groups:
haemorrhagic gastritis, bloody content of intestine, acute peritonitis, local adhesions of stomach and liver, single animals with acute serous peritonitis as a result of perforation of the stomach, single animals with very severe tymanitas, one animal with perforated duodenal ulcer, swollen margo plicatus (cuticular ridge)

lowest dosing group:
1 male with acute lung emphysema and haemorrhagic intestinal content, other animals without findings

Applicant's summary and conclusion